Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (231-240 of 778) with videos related to

Pageof 78
Sort By:
The American Journal of Cardiology|March 16, 2026
A Misleading Case of Persistent Chest PainDiego Nastasi, Paola Pruiti, Angelo Di Grazia, et al.
Expert Opinion on Pharmacotherapy|January 24, 2023
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationAntonio Greco, Simone Finocchiaro, Dominick J Angiolillo, et al.
Expert Review of Cardiovascular Therapy|August 7, 2019
Aspirin for the primary prevention of cardiovascular disease: latest evidenceDavide Capodanno, Salvatore Ingala, Dario Calderone, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery diseaseStéphane Cook, Holger Nef, Davide Capodanno, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2020
Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI surveyMarco Roffi, Davide Capodanno, Stephan Windecker, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Pageof 78

Showing results (231-240 of 778) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|March 16, 2026
A Misleading Case of Persistent Chest PainDiego Nastasi, Paola Pruiti, Angelo Di Grazia, et al.
Expert Opinion on Pharmacotherapy|January 24, 2023
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationAntonio Greco, Simone Finocchiaro, Dominick J Angiolillo, et al.
Expert Review of Cardiovascular Therapy|August 7, 2019
Aspirin for the primary prevention of cardiovascular disease: latest evidenceDavide Capodanno, Salvatore Ingala, Dario Calderone, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery diseaseStéphane Cook, Holger Nef, Davide Capodanno, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 4, 2020
Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI surveyMarco Roffi, Davide Capodanno, Stephan Windecker, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Pageof 78